Acquisition by Torrente Josephine of 935 shares of Agile Thrpe subject to Rule 16b-3
AGRXDelisted Stock | USD 2.94 0.08 2.65% |
Slightly above 62% of Agile Thrpe's investor base is looking to short. The analysis of current outlook of investing in Agile Thrpe suggests that many traders are alarmed regarding Agile Thrpe's prospects. Agile Thrpe's investing sentiment can be driven by a variety of factors including economic data, Agile Thrpe's earnings reports, geopolitical events, and overall market trends.
Agile |
Filed transaction by Agile Therapeutics Inc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Agile Thrpe Fundamental Analysis
We analyze Agile Thrpe's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Agile Thrpe using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Agile Thrpe based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Market Capitalization
Market Capitalization Comparative Analysis
Agile Thrpe is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Agile Thrpe Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Agile Thrpe stock to make a market-neutral strategy. Peer analysis of Agile Thrpe could also be used in its relative valuation, which is a method of valuing Agile Thrpe by comparing valuation metrics with similar companies.
Peers
Agile Thrpe Related Equities
PRFX | Painreform | 13.67 | ||||
AMRX | Amneal Pharmaceuticals, | 3.63 | ||||
LFCR | Lifecore Biomedical | 2.97 | ||||
ASRT | Assertio Therapeutics | 2.00 | ||||
TKNO | Alpha Teknova | 1.61 | ||||
EVOK | Evoke Pharma | 1.81 | ||||
SHPH | Shuttle Pharmaceuticals | 4.71 | ||||
AQST | Aquestive Therapeutics | 5.50 | ||||
CYTH | Cyclo Therapeutics | 5.88 | ||||
PTPI | Petros Pharmaceuticals | 6.90 | ||||
CPIX | Cumberland Pharmaceuticals | 7.14 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Agile Stock
If you are still planning to invest in Agile Thrpe check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Agile Thrpe's history and understand the potential risks before investing.
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Stocks Directory Find actively traded stocks across global markets | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |